The p-benzoquinone DNA adducts derived from benzene are highly mutagenic

Zhongwen Xie, Yanbin Zhang, Anton B. Guliaev, Huiyun Shen, Bo Hang, B. Singer, Zhigang Wang

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Benzene is a human leukemia carcinogen, resulting from its cellular metabolism. A major benzene metabolite is p-benzoquinone (pBQ), which can damage DNA by forming the exocyclic base adducts pBQ-dC, pBQ-dA, and pBQ-dG in vitro. To gain insights into the role of pBQ in benzene genotoxicity, we examined in vitro translesion synthesis and in vivo mutagenesis of these pBQ adducts. Purified REV1 and Polκ were essentially incapable of translesion synthesis in response to the pBQ adducts. Opposite pBQ-dA and pBQ-dC, purified human Polι was capable of error-prone nucleotide insertion, but was unable to perform extension synthesis. Error-prone translesion synthesis was observed with Polη. However, DNA synthesis largely stopped opposite the lesion. Consistent with in vitro results, replication of site-specifically damaged plasmids was strongly inhibited by pBQ adducts in yeast cells, which depended on both Polζ and Polη. In wild-type cells, the majority of translesion products were deletions at the site of damage, accounting for 91%, 90%, and 76% for pBQ-dA, pBQ-dG, and pBQ-dC, respectively. These results show that the pBQ-dC, pBQ-dA, and pBQ-dG adducts are strong blocking lesions, and are highly mutagenic by predominantly inducing deletion mutations. These results are consistent with the lesion structures predicted by molecular dynamics simulation. Our results led to the following model. Translesion synthesis normally occurs by directly copying the lesion site through base insertion and extension synthesis. When the lesion becomes incompatible in accommodating a base opposite the lesion in DNA, translesion synthesis occurs by a less efficient lesion loop-out mechanism, resulting in avoiding copying the damaged base and leading to deletion.

Original languageEnglish
Pages (from-to)1399-1409
Number of pages11
JournalDNA Repair
Volume4
Issue number12
DOIs
StatePublished - Dec 8 2005
Externally publishedYes

Fingerprint

DNA Adducts
Benzene
Copying
benzoquinone
DNA
Mutagenesis
Sequence Deletion
Molecular Dynamics Simulation
Metabolites
Metabolism
Carcinogens
Yeast

Keywords

  • Benzene
  • DNA adducts
  • Lesion bypass
  • Mutagenesis
  • Polymerase ζ
  • Translesion synthesis
  • Y family DNA polymerase

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Xie, Z., Zhang, Y., Guliaev, A. B., Shen, H., Hang, B., Singer, B., & Wang, Z. (2005). The p-benzoquinone DNA adducts derived from benzene are highly mutagenic. DNA Repair, 4(12), 1399-1409. https://doi.org/10.1016/j.dnarep.2005.08.012

The p-benzoquinone DNA adducts derived from benzene are highly mutagenic. / Xie, Zhongwen; Zhang, Yanbin; Guliaev, Anton B.; Shen, Huiyun; Hang, Bo; Singer, B.; Wang, Zhigang.

In: DNA Repair, Vol. 4, No. 12, 08.12.2005, p. 1399-1409.

Research output: Contribution to journalArticle

Xie, Z, Zhang, Y, Guliaev, AB, Shen, H, Hang, B, Singer, B & Wang, Z 2005, 'The p-benzoquinone DNA adducts derived from benzene are highly mutagenic', DNA Repair, vol. 4, no. 12, pp. 1399-1409. https://doi.org/10.1016/j.dnarep.2005.08.012
Xie, Zhongwen ; Zhang, Yanbin ; Guliaev, Anton B. ; Shen, Huiyun ; Hang, Bo ; Singer, B. ; Wang, Zhigang. / The p-benzoquinone DNA adducts derived from benzene are highly mutagenic. In: DNA Repair. 2005 ; Vol. 4, No. 12. pp. 1399-1409.
@article{d717beb7cb644c5c99d02e634b3abe97,
title = "The p-benzoquinone DNA adducts derived from benzene are highly mutagenic",
abstract = "Benzene is a human leukemia carcinogen, resulting from its cellular metabolism. A major benzene metabolite is p-benzoquinone (pBQ), which can damage DNA by forming the exocyclic base adducts pBQ-dC, pBQ-dA, and pBQ-dG in vitro. To gain insights into the role of pBQ in benzene genotoxicity, we examined in vitro translesion synthesis and in vivo mutagenesis of these pBQ adducts. Purified REV1 and Polκ were essentially incapable of translesion synthesis in response to the pBQ adducts. Opposite pBQ-dA and pBQ-dC, purified human Polι was capable of error-prone nucleotide insertion, but was unable to perform extension synthesis. Error-prone translesion synthesis was observed with Polη. However, DNA synthesis largely stopped opposite the lesion. Consistent with in vitro results, replication of site-specifically damaged plasmids was strongly inhibited by pBQ adducts in yeast cells, which depended on both Polζ and Polη. In wild-type cells, the majority of translesion products were deletions at the site of damage, accounting for 91{\%}, 90{\%}, and 76{\%} for pBQ-dA, pBQ-dG, and pBQ-dC, respectively. These results show that the pBQ-dC, pBQ-dA, and pBQ-dG adducts are strong blocking lesions, and are highly mutagenic by predominantly inducing deletion mutations. These results are consistent with the lesion structures predicted by molecular dynamics simulation. Our results led to the following model. Translesion synthesis normally occurs by directly copying the lesion site through base insertion and extension synthesis. When the lesion becomes incompatible in accommodating a base opposite the lesion in DNA, translesion synthesis occurs by a less efficient lesion loop-out mechanism, resulting in avoiding copying the damaged base and leading to deletion.",
keywords = "Benzene, DNA adducts, Lesion bypass, Mutagenesis, Polymerase ζ, Translesion synthesis, Y family DNA polymerase",
author = "Zhongwen Xie and Yanbin Zhang and Guliaev, {Anton B.} and Huiyun Shen and Bo Hang and B. Singer and Zhigang Wang",
year = "2005",
month = "12",
day = "8",
doi = "10.1016/j.dnarep.2005.08.012",
language = "English",
volume = "4",
pages = "1399--1409",
journal = "DNA Repair",
issn = "1568-7864",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - The p-benzoquinone DNA adducts derived from benzene are highly mutagenic

AU - Xie, Zhongwen

AU - Zhang, Yanbin

AU - Guliaev, Anton B.

AU - Shen, Huiyun

AU - Hang, Bo

AU - Singer, B.

AU - Wang, Zhigang

PY - 2005/12/8

Y1 - 2005/12/8

N2 - Benzene is a human leukemia carcinogen, resulting from its cellular metabolism. A major benzene metabolite is p-benzoquinone (pBQ), which can damage DNA by forming the exocyclic base adducts pBQ-dC, pBQ-dA, and pBQ-dG in vitro. To gain insights into the role of pBQ in benzene genotoxicity, we examined in vitro translesion synthesis and in vivo mutagenesis of these pBQ adducts. Purified REV1 and Polκ were essentially incapable of translesion synthesis in response to the pBQ adducts. Opposite pBQ-dA and pBQ-dC, purified human Polι was capable of error-prone nucleotide insertion, but was unable to perform extension synthesis. Error-prone translesion synthesis was observed with Polη. However, DNA synthesis largely stopped opposite the lesion. Consistent with in vitro results, replication of site-specifically damaged plasmids was strongly inhibited by pBQ adducts in yeast cells, which depended on both Polζ and Polη. In wild-type cells, the majority of translesion products were deletions at the site of damage, accounting for 91%, 90%, and 76% for pBQ-dA, pBQ-dG, and pBQ-dC, respectively. These results show that the pBQ-dC, pBQ-dA, and pBQ-dG adducts are strong blocking lesions, and are highly mutagenic by predominantly inducing deletion mutations. These results are consistent with the lesion structures predicted by molecular dynamics simulation. Our results led to the following model. Translesion synthesis normally occurs by directly copying the lesion site through base insertion and extension synthesis. When the lesion becomes incompatible in accommodating a base opposite the lesion in DNA, translesion synthesis occurs by a less efficient lesion loop-out mechanism, resulting in avoiding copying the damaged base and leading to deletion.

AB - Benzene is a human leukemia carcinogen, resulting from its cellular metabolism. A major benzene metabolite is p-benzoquinone (pBQ), which can damage DNA by forming the exocyclic base adducts pBQ-dC, pBQ-dA, and pBQ-dG in vitro. To gain insights into the role of pBQ in benzene genotoxicity, we examined in vitro translesion synthesis and in vivo mutagenesis of these pBQ adducts. Purified REV1 and Polκ were essentially incapable of translesion synthesis in response to the pBQ adducts. Opposite pBQ-dA and pBQ-dC, purified human Polι was capable of error-prone nucleotide insertion, but was unable to perform extension synthesis. Error-prone translesion synthesis was observed with Polη. However, DNA synthesis largely stopped opposite the lesion. Consistent with in vitro results, replication of site-specifically damaged plasmids was strongly inhibited by pBQ adducts in yeast cells, which depended on both Polζ and Polη. In wild-type cells, the majority of translesion products were deletions at the site of damage, accounting for 91%, 90%, and 76% for pBQ-dA, pBQ-dG, and pBQ-dC, respectively. These results show that the pBQ-dC, pBQ-dA, and pBQ-dG adducts are strong blocking lesions, and are highly mutagenic by predominantly inducing deletion mutations. These results are consistent with the lesion structures predicted by molecular dynamics simulation. Our results led to the following model. Translesion synthesis normally occurs by directly copying the lesion site through base insertion and extension synthesis. When the lesion becomes incompatible in accommodating a base opposite the lesion in DNA, translesion synthesis occurs by a less efficient lesion loop-out mechanism, resulting in avoiding copying the damaged base and leading to deletion.

KW - Benzene

KW - DNA adducts

KW - Lesion bypass

KW - Mutagenesis

KW - Polymerase ζ

KW - Translesion synthesis

KW - Y family DNA polymerase

UR - http://www.scopus.com/inward/record.url?scp=27844460203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27844460203&partnerID=8YFLogxK

U2 - 10.1016/j.dnarep.2005.08.012

DO - 10.1016/j.dnarep.2005.08.012

M3 - Article

C2 - 16181813

AN - SCOPUS:27844460203

VL - 4

SP - 1399

EP - 1409

JO - DNA Repair

JF - DNA Repair

SN - 1568-7864

IS - 12

ER -